XML 68 R46.htm IDEA: XBRL DOCUMENT v3.22.2
Note 6 - Contingent Consideration (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Sep. 30, 2021
Apr. 19, 2019
Dec. 20, 2018
May 31, 2022
Apr. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Jul. 31, 2021
Apr. 30, 2019
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2022
Nov. 30, 2021
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability                       $ (1,943,000) $ (6,871,000)   $ (8,246,000) $ 10,500,000    
Business Combination, Contingent Consideration, Liability, Noncurrent $ 702,000   $ 9,856,000                 702,000   $ 702,000 702,000      
Restricted Stock Units (RSUs) [Member] | Share-Based Payment Arrangement, Employee [Member]                                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)                                   120,000
Restricted Stock Units (RSUs) [Member] | Share-Based Payment Arrangement, Employee [Member] | Minimum [Member]                                    
Share-based Compensation Arrangement by Share-based Payment Award, Terms, Generated Net Sales, Amount                                 $ 3,000,000  
Restricted Stock Units (RSUs) [Member] | Share-Based Payment Arrangement, Employee [Member] | Maximum [Member]                                    
Share-based Compensation Arrangement by Share-based Payment Award, Terms, Generated Net Sales, Amount                                 $ 8,000,000  
Share-Based Payment Arrangement, Option [Member]                                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee (in shares)             100,000                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Minimum Consumer Revenue Required             $ 12,000,000.0                      
Employee-related Liabilities, Total 0                     0   0 0      
Cure Based Development, Llc [Member] | Common Stock [Member]                                    
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)                     15,250,000              
Business Acquisition, Equity Interest Issued or Issuable, Vesting Period (Year)                     5 years              
Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares (in shares)           458,877   444,243 466,713   15,250,000              
Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares, Expiration (Month)         60 months                          
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable       $ 53,215,163                            
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability           $ 90,792   $ 41,914 $ (366,841)                  
Business Combination, Contingent Consideration, Liability, Current   $ 405,000       $ 178,000   325,000 405,000                  
Business Combination, Contingent Consideration, Liability, Noncurrent $ 702,000   9,440,000                 $ 702,000   $ 702,000 $ 702,000      
Business Acquisition, Equity Interest Issued or Issuable, Number of Remaining Earnout Shares Subject to Issuance (in shares) 4,338,302                     4,338,302   4,338,302 4,338,302      
Cure Based Development, Llc [Member] | Registered Common Stock [Member]                                    
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)                     6,500,000              
Cure Based Development, Llc [Member] | Unregistered Common Stock [Member]                                    
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) 4,338,302                   8,750,000              
Business Acquisition, Equity Interest Issued or Issuable, Vesting Period (Year)                     5 years              
Twenty Two Acquisition [Member] | Common Stock [Member]                                    
Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares (in shares)                   200,000                
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability   (255,000) (73,561)         148,000           $ 13,000        
Business Combination, Contingent Consideration, Liability, Noncurrent $ 0 $ 161,000 $ 416,000         $ 13,000 $ 161,000 $ 488,561   $ 0   $ 0 $ 0